Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
by Euan Ashley, Josef Niebauer - Remedica Publishing
The book on physiologic and pathophysiologic mechanisms of cardiovascular disease, gives guidelines as to when refer to specialist colleagues and explains what the specialist is likely to do. Aimed at the hospital doctor, generalist or student.
- Royal College of Physicians
The guideline covers aspects of diagnosis and the management of atrial fibrillation (AF) in a number of different circumstances. It covers paroxysmal, persistent and permanent AF, and considers AF developing after surgical procedures.
by Jose A. Morales Gonzalez (ed.) - InTech
This publication systematizes the knowledge necessary to make Cardiopulmonary Resuscitation or Cardiorespiratory Resuscitation known to nursing health specialists, which translates as a set of temporary and internationally standardized maneuvers...
by W Schuyler Jones, et al. - Agency for Healthcare Research and Quality
This review assessed the comparative effectiveness of antiplatelet therapy, medical therapy, exercise, and endovascular and surgical revascularization in PAD patients with intermittent claudication (IC) or critical limb ischemia (CLI).